Newbridge Financial Services Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Newbridge Financial Services Group's PFE Position: Q2 2026 in Review
Newbridge Financial Services Group increased its Pfizer (PFE) stake by 13% in Q2 2026, buying an estimated $37.3K and bringing the position to 12,510 shares worth $301K. The position accounts for 0.04% of the portfolio, ranked #199.
Newbridge Financial Services Group first reported a position in PFE in Q3 2020 and has held it in 23 quarters since. The position peaked at $590K in Q4 2022. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Newbridge Financial Services Group held 12,510 shares of Pfizer worth $301K as of Q2 2026.
- Newbridge Financial Services Group bought 1,426 Pfizer shares in Q2 2026, an estimated $37.3K.
- Pfizer made up 0.04% of Newbridge Financial Services Group's portfolio in Q2 2026, its #199 holding.
- Newbridge Financial Services Group first reported a position in Pfizer in Q3 2020 and has held it in 23 quarters since.
- Newbridge Financial Services Group's Pfizer position peaked at $590K in Q4 2022.
- 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.